FDA, Fluoride
Digest more
The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events. As of May 7, 17 serious events, including two deaths, have been reported in people ages 62 to 89 who received the Ixchiq vaccine. Six of the reports have been in the U.S.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the American public.”
The agency says ingestible fluoride is linked to various adverse health effects, but dental groups say it is 'essential' for cavity prevention, particularly among people who can't afford to regularly visit a dentist.
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received previous treatment, the drugmaker said on Wednesday.
Explore more
Healthy persons infected with salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain.
An ingestible fluoride prescription drug product for children was pulled from the market on Tuesday after the Food and Drug Administration (FDA) said it was never approved. The products are known as fluoride tablets, according to NPR. These include drops or lozenges meant for children who don’t get fluoridated water to help prevent cavities.
The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's restructuring aims to streamline functions such as IT and communications, and reduce conflicts of interest among its staff and advisors.
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two related deaths, according to the FDA and CDC.
The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two types adrenal gland tumors.